Subscribe To
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October

Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced presentations featuring results from […] The post Ocuphire Pharma to Present at Euretina and Retina Society Confere...
Read More
Posted: Oct 6 2023, 12:00
Author Name: forextv
Views: 082778